INTEGRATED USE OF ECHOCARDIOGRAPHY AND SPIROMETRY IN EVALUATING PATIENTS WITH BRONCHIAL ASTHMA IN A TERTIARY CARE HOSPITAL AT NORTH KERALA: A CROSS-SECTIONAL STUDY

Main Article Content

Vidhiyasagaran J
Pallavi Kulkarni
James P.T
Manimekalai K

Keywords

Asthma, cardiovascular disease, spirometry, echocardiography

Abstract

Bronchial asthma and coronary vascular disease often co-exist, as they share many common risk factors in their etiopathogenesis. The persistent hypoxia in bronchial asthma compromises cardiovascular haemodynamic to a greater extent. Our objective was to assess the cardiac changes by echocardiography in patients with bronchial asthma and to correlate with its severity and pulmonary function test parameters. A total of 130 patients were selected and classified based on their severity, as per GINA (Global Initiative for Asthma) guidelines. All patients underwent spirometry and echocardiography evaluation. On echocardiographic evaluation, 59.3 % patients had abnormal findings. Majority of cases (60%) had pulmonary hypertension (PH) and the incidence of PH was more in the uncontrolled asthma group (44.4%). The frequency of cor pulmonale and tricuspid regurgitation (TR) were 3.08% and 5.38% respectively. There was a significant association (p <0.05) with a positive correlation between the severity of asthma and frequency of PH, LVDD (Left Ventricular Diastolic Dysfunction) and cor pulmonale.


There was a significant (p<0.05) positive correlation between the echo parameter ejection expressed as percentage (EF%) and spirometry parameters. But there was a negative correlation between spirometry parameters and echo parameters PH and LVDD. To conclude, the prevalence of cardiac dysfunction showed a liner relationship with the severity of asthma and pulmonary function parameters, especially, PH and LVDD with a statistical significance (p<0.05). Echocardiography detects cardiovascular abnormality in asthma patients at the subclinical stage and helps in the improvement of health care.

Abstract 79 | pdf Downloads 63

References

1. Krishnan A, Khurana S, Sharma S, Menon GR. Estimates of major non-communicable disease risk factors for India, 2010 & 2015: A summary of evidence. Indian J Med Res. 2022 Jul;156(1):56-63. doi: 10.4103/ijmr.IJMR_3275_20. PMID: 36510898; PMCID: PMC9903385.
2. 2.Zhang B, Li ZF, An ZY, Zhang L, Wang JY, Hao MD, Jin YJ, Li D, Song AJ, Ren Q, Chen WB. Association Between Asthma and All-Cause Mortality and Cardiovascular Disease Morbidity and Mortality: A Meta-Analysis of Cohort Studies. Front Cardiovasc Med. 2022 Mar 17; 9:861798. doi: 10.3389/fcvm.2022.861798. PMID: 35369308; PMCID: PMC8968068.
3. 3.Ramalho SHR, Shah AM. Lung function and cardiovascular disease: A link. Trends Cardiovasc Med. 2021 Feb;31(2):93-98. doi: 10.1016/j.tcm.2019.12.009. Epub 2020 Jan 3. PMID: 31932098; PMCID: PMC7332411.
4. 4.Habib N, Pasha MA, Tang DD. Current Understanding of Asthma Pathogenesis and Biomarkers. Cells. 2022 Sep 5;11(17):2764. doi: 10.3390/cells11172764. PMID: 36078171; PMCID: PMC9454904.
5. 5.Fehrenbach H, Wagner C, Wegmann M. Airway remodelling in asthma: what really matters. Cell Tissue Res. 2017 Mar;367(3):551-569. doi: 10.1007/s00441-016-2566-8. Epub 2017 Feb 11. PMID: 28190087; PMCID: PMC5320023.
6. 6.Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019 Jan 24;53(1):1801914. doi: 10.1183/13993003.01914-2018. PMID: 30545980; PMCID: PMC6351338.
7. 7.Caplan M, Hamzaoui O. Cardio-respiratory interactions in acute asthma. Front Physiol. 2023 Sep 15; 14:1232345. doi: 10.3389/fphys.2023.1232345. PMID: 37781226; PMCID: PMC10540856.
8. 8.Tuffet S, Maraffi T, Lacheny M, Perier F, Haudebourg AF, Boujelben MA, Alcala G, Mekontso-Dessap A, Carteaux G. Impact of cardiac output and alveolar ventilation in estimating ventilation/perfusion mismatch in ARDS using electrical impedance tomography. Crit Care. 2023 May 8;27(1):176. doi: 10.1186/s13054-023-04467-w. PMID: 37158963; PMCID: PMC10165791.
9. 9.Maule M, Olivieri B, Guarnieri G, De Franceschi L, Martinelli N, Vaia R, Argentino G, Vianello A, Senna G, Caminati M. Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach. J Clin Med. 2023 Mar 15;12(6):2294. doi: 10.3390/jcm12062294. PMID: 36983294; PMCID: PMC10059265.
10. 10.Gkavogiannakis NA, Tsoporis JN, Drosatos IA, Tsirebolos G, Izhar S, Sakadakis E, Triantafyllis AS, Parker TG, Kalogiros LA, Leong-Poi H, Rallidis LS, Rizos I. Emergent Inflammatory Markers and Echocardiographic Indices in Patients with Bronchial Asthma. Biomolecules. 2023 Jun 7;13(6):955. doi: 10.3390/biom13060955. PMID: 37371535; PMCID: PMC10296420.
11. 11.Kundavaram R, Kumar P, Malik S, Bhatt G, Gogia P, Kumar A. Impact of Asthma Phenotypes on Myocardial Performance and Pulmonary Hypertension in Children and Adolescents with Moderate to Severe Persistent Asthma. Cureus. 2023 Aug 28;15(8):e44252. doi: 10.7759/cureus.44252. PMID: 37772232; PMCID: PMC10525984.
12. 12.De-Paula CR, Magalhães GS, Jentzsch NS, Botelho CF, Mota CCC, Murça TM, Ramalho LFC, Tan TC, Capuruço CAB, Rodrigues-Machado MDG. Echocardiographic Assessment of Ventricular Function in Young Patients with Asthma. Arq Bras Cardiol. 2018 Mar;110(3):231-239. doi: 10.5935/abc.20180052. PMID: 29694547; PMCID: PMC5898772.
13. 13.Di Raimondo D, Musiari G, Rizzo G, Pirera E, Benfante A, Battaglia S, Colomba D, Tuttolomondo A, Scichilone N, Pinto A. Echocardiographic Evaluation of the Cardiac Chambers in Asthmatic Patients: The BADA (Blood Pressure Levels, Clinical Features and Markers of Subclinical Cardiovascular Damage of Asthma Patients) Study-ECO. J Pers Med. 2022 Nov 5;12(11):1847. doi: 10.3390/jpm12111847. PMID: 36579553; PMCID: PMC9694451.
14. 14.Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations.
15. 15.Gutierrez CG, Bukstein DA. Functionality of the Asthma Impairment and Risk Questionnaire and its implications in shared decision-making. Annals of Allergy, Asthma & Immunology. 2024 Jul 1;133(1):5-6.
16. 16.Chemla D, Castelain V, Humbert M, Hébert JL, Simonneau G, Lecarpentier Y, Hervé P. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest. 2004 Oct 1;126(4):1313-7.
17. 17.Parasuraman S, Walker S, Loudon BL, Gollop ND, Wilson AM, Lowery C, Frenneaux MP. Assessment of pulmonary artery pressure by echocardiography—a comprehensive review. IJC Heart & Vasculature. 2016 Sep 1; 12:45-51.
18. 18.Mitter SS, Shah SJ, Thomas JD. A test in context: E/A and E/e′ to assess diastolic dysfunction and LV filling pressure. Journal of the American College of Cardiology. 2017 Mar 21;69(11):1451-64.
19. 19.Ash SY, Sanchez-Ferrero GV, Schiebler ML, Rahaghi FN, Rai A, Come CE, Ross JC, Colon AG, Cardet JC, Bleecker ER, Castro M. Estimated Ventricular Size, Asthma Severity, and Exacerbations: The Severe Asthma Research Program III Cohort. Chest. 2020 Feb 1;157(2):258-67.
20. 20.Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. American journal of respiratory and critical care medicine. 2022 Jan 1;205(1):17-35.
21. 21.Ramasamy AK, Gupta N, Kumar R. Impact of obesity on bronchial asthma in Indian population. Lung India. 2014 Apr 1;31(2):121-6.
22. 22.Tattersall MC, Guo M, Korcarz CE, Gepner AD, Kaufman JD, Liu KJ, Barr RG, Donohue KM, McClelland RL, Delaney JA, Stein JH. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2015 Jun;35(6):1520-5.
23. 23.Zorlu D, Boduroğlu Y, Ertürk A. Echocardiographic evaluation from a different perspective in asthmatic patients. Tuberk Toraks. 2022 Jun;70(2):166-178. English. doi: 10.5578/tt.20229807. PMID: 35785881.
24. 24.Ferrara F, Zhou X, Gargani L, Wierzbowska-Drabik K, Vriz O, Fadel BM, Stanziola AA, Kasprzak J, Vannan M, Bossone E. Echocardiography in pulmonary arterial hypertension. Current Cardiology Reports. 2019 Apr; 21:1-0.
25. 25.Sundar KM, Willis A, Ross DS. Clinical Course of Patients with Pulmonary Hypertension Secondary to Diastolic Dysfunction, Obesity, And Sleep Apnoea. InD34. PULMONARY HYPERTENSION: ENDPOINTS AND OUTCOMES 2011 May (pp. A5944-A5944). American Thoracic Society.
26. 26.Ghandi Y, Habibi D. The influence of asthma on right ventricular systolic and diastolic function in children according to tissue doppler echocardiography. Journal of Kerman University of Medical Sciences. 2019 May 1;26(3):192-299.
27. 27.Hirono O, Kubota I, Minamihaba O, Fatema K, Kato S, Nakamura H, Tomoike H. Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral β2-adrenoceptor agonists. American Heart Journal. 2001 Dec 1;142(6):5A-10A.
28. 28.Carr TF, Altisheh R, Zitt M. Small airways disease and severe asthma. World Allergy Organization Journal. 2017 Dec; 10:1-9.